Cargando…
Review of Current Systemic Therapy and Novel Systemic Therapy for Pancreatic Ductal Adenocarcinoma
Background: This review aims to describe the systemic treatment options for pancreatic ductal adenocarcinoma and includes a summary of the current treatments as well as the ongoing clinical trials which may be efficacious in the treatment of this aggressive malignancy. Methods: A literature review w...
Autores principales: | Sarfraz, Humaira, Saha, Aditi, Jhaveri, Khushali, Kim, Dae Won |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296812/ https://www.ncbi.nlm.nih.gov/pubmed/37366887 http://dx.doi.org/10.3390/curroncol30060404 |
Ejemplares similares
-
PB2602: POPULATION-BASED STUDY OF HEMOLYTIC UREMIC SYNDROME HOSPITALIZATIONS.
por: Jhaveri, Khushali, et al.
Publicado: (2023) -
Systemic therapy in pancreatic ductal adenocarcinomas (PDACs)—basis and current status
por: Ramaswamy, Anant, et al.
Publicado: (2022) -
Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies
por: Adamska, Aleksandra, et al.
Publicado: (2017) -
Current and Future Therapies for Pancreatic Ductal Adenocarcinoma
por: Sally, Áine, et al.
Publicado: (2022) -
Role of the microbiome in systemic therapy for pancreatic ductal adenocarcinoma (Review)
por: Huang, Xing, et al.
Publicado: (2021)